Figure 1From: A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer Overall and Progression-Free Survival. (A) Kaplan-Meier estimates of overall survival and progression-free survival in patients treated with PLD for metastatic breast cancer. (B) Kaplan-Meier estimates of overall survival and progression-free survival in anthracycline-pretreated patients treated with PLD for metastatic breast cancer.Back to article page